|
Originally published In Press as doi:10.1074/jbc.M204122200 on June 20, 2002
J. Biol. Chem., Vol. 277, Issue 36, 32714-32721, September 6, 2002
The Linker Region Plays an Important Role in the Interdomain
Communication of the Response Regulator OmpR*
Kirsten
Mattison ,
Ricardo
Oropeza§, and
Linda J.
Kenney¶
From the Department of Molecular Microbiology and Immunology,
Oregon Health and Science University, Portland, Oregon 97239
Received for publication, April 29, 2002, and in revised form, June 8, 2002
 |
ABSTRACT |
OmpR is the response regulator of a two-component
regulatory system that controls the expression of the porin genes
ompF and ompC in Escherichia coli.
This regulator consists of two domains joined by a flexible
linker region. The amino-terminal domain is phosphorylated by the
sensor kinase EnvZ, and the carboxyl-terminal domain binds DNA via a
winged helix-turn-helix motif. In vitro studies have shown
that amino-terminal phosphorylation enhances the DNA binding affinity
of OmpR and, conversely, that DNA binding by the carboxyl
terminus increases OmpR phosphorylation. In the present work, we
demonstrate that the linker region contributes to this communication
between the two domains of OmpR. Changing the specific amino acid
composition of the linker alters OmpR function, as does increasing or
decreasing its length. Three linker mutants give rise to an
OmpF+ OmpC phenotype, but the defects are not
due to a shared molecular mechanism. Currently, functional homology
between response regulators is predicted based on similarities in the
amino and carboxyl-terminal domains. The results presented here
indicate that linker length and composition should also be considered.
Furthermore, classification of response regulators in the same
subfamily does not necessarily imply that they share a common response mechanism.
 |
INTRODUCTION |
Two-component signaling systems are the predominant signal
transduction pathways in prokaryotes, and the components are highly conserved (1). In Escherichia coli, a two-component system that consists of the sensor kinase EnvZ and the response regulator OmpR
regulates the expression of the outer membrane porins OmpF and OmpC in
response to environmental osmolarity. At low osmolarity, OmpF
predominates in the outer membrane; OmpC is expressed at high
osmolarity (2). In response to an unidentified environmental signal,
the EnvZ kinase autophosphorylates at histidine 243 and transfers the
phosphoryl group to aspartate 55 of OmpR (3-5). At low osmolarity
OmpR-P1 activates
transcription of ompF, whereas at high osmolarity OmpR-P represses ompF transcription and activates transcription of
ompC (5, 6).
OmpR consists of an amino-terminal phosphorylation domain and a
carboxyl-terminal DNA-binding domain, which are joined by a linker
region (7, 8). The two domains of OmpR influence each other.
Phosphorylation of OmpR at the amino-terminal aspartate 55 increases
the DNA binding affinity of the carboxyl terminus (9-12). Conversely,
the presence of specific DNA binding sites increases the steady-state
amount of OmpR-P formed in vitro (13, 14). Our laboratory is
interested in determining the mechanism responsible for this
interdomain communication in OmpR.
The linker regions of response regulators are not highly homologous;
however, they are relatively rich in glutamine, arginine, glutamate,
serine, and proline residues (15, 16). These linker regions have no
predicted secondary structure. Wootton and Drummond (15) termed these
sequences Q-linkers because of the preponderance of glutamine residues.
These authors suggested that the Q-linkers serve the simple role of
tethering the two domains to allow functional interactions to occur.
However, point mutants have been isolated in the linker region of both
OmpR and the homologous regulator DmsR that disrupt protein function
(17-19). It was therefore of interest to determine whether specific
amino acids were required for interdomain communication of OmpR. In the
present work, we have analyzed the effect of replacing the linker
region with different amino acid sequences and found that some, but not
all, linker substitutions allow OmpR-mediated transcriptional
activation of the ompF and ompC genes.
OmpR orthologues are very highly conserved among enteric bacteria such
as Salmonella typhi, Salmonella
typhimurium, Yersinia enterocolitica,
Yersinia pestis, Enterobacter cloacae, and
Shigella flexnerii. As such, although the linker sequences
are conserved, it is impossible to determine whether this has
functional significance, as the entire protein varies by only 1-8
residues. Among more divergent species such as Xenorhabdus
nematophilus, Vibrio cholerae, and
Pseudomonas aeruginosa, it appears that a central PGAP
sequence (residues 128-131 in OmpR) is more highly conserved than the
rest of the linker; this is where the previously isolated point mutants are located (17-19).
The Q-linkers of response regulators vary greatly in length as well as
in sequence composition. For example, two highly homologous regulators
from the same subfamily, OmpR and PhoB, have linker regions of 15 and 6 amino acid residues, respectively (20, 21, 34). An understanding of the
molecular mechanism for transmitting information between the two
domains will depend upon understanding the interface that connects
them. As the putative interdomain interface might vary with linker
length, it is useful to understand the required length of the linker
region for each regulator. Here we express OmpR constructs encoding
linkers of various lengths and find that alterations in linker length
impair OmpR function.
In our analysis of several linker mutants, it was striking that three
different substitutions resulted in an OmpF+
OmpC phenotype. An examination of these OmpR mutants
revealed that their porin gene expression profiles are similar, and yet
they differ in their phosphorylation and DNA binding properties. Thus, there are different molecular mechanisms by which an OmpR linker mutant
may present an OmpF+ OmpC phenotype in
vivo.
 |
EXPERIMENTAL PROCEDURES |
Construction of Mutants--
ompR was subcloned into
the Bluescript KS vector using HindIII and XbaI
sites. To create some of the mutations, two complementary oligonucleotides containing the desired mutation were used in a PCR
reaction as described (22, 23). These oligonucleotides are listed in
Table I as group A. The linker is defined in this case based on
structural determination by x-ray crystallography (20, 21). The linker
is defined by the lack of electron density, and its edges are the first
residue after the 5 helix in the receiver (amino terminus) domain
and the last residue before the strand of the carboxyl-terminal
DNA-binding domain. To create the linker substitutions, the endogenous
SalI and DraI sites were removed from the
pBluescript vector, and silent SalI and DraI sites were created in ompR flanking the linker region. This
mutagenesis was by the same PCR reaction (22, 23). The oligonucleotides used for construction of this vector are listed as group B in Table I.
Oligonucleotides corresponding to new linker sequences were then
synthesized, annealed, and ligated into the vector at these now unique
SalI and DraI sites. The oligonucleotides used in
this approach are listed as group C in Table
I. All of the linker mutants in the
strain MH225.101 except Q9 were found to be expressed in soluble form
by Western blot analysis.
Protein Purification--
OmpR, G129D, P131S and GGK were
expressed and purified as described (10, 24).
-Galactosidase Assays--
All of the linker mutants were
subcloned into pFR29* using the XbaI and HindIII
sites. pFR29* is a derivative of pFR29 from which the
envZ gene has been excised (25). The plasmids were used to transform strains MH225.101 and MH513.101. The MH225.101 genotype is F lacU169 araD139 rpsL relA thiA
malQ7 ompR101 (ompC-lacZ+)10-21, and
the genotype of MH513.101 is F (lac) U169 rpsL
relA thiA flbB ompR101
(ompF-lacZ+) 16-13 (26, 27).
Liquid -galactosidase assays were performed exactly as described
(22).
Phosphorylation Assays and Measurement of ATPase
Activity--
Phosphorylation reactions were carried out with EnvZ115
as described (24). ATPase reactions were carried out as described (24).
DNase I Footprinting--
DNA was prepared as described (22).
The proteins were phosphorylated with 25 mM acetyl
phosphate (OmpR and GGK) or 25 mM phosphoramidate (OmpR,
G129D, and P131S) in phosphorylation buffer (50 mM Tris (pH
7.5), 50 mM KCl, 20 mM MgCl2) for
3 h (acetyl phosphate) or 1 h (phosphoramidate) at room
temperature. The amount of OmpR-P was determined to be 74% by C4
reversed phase HPLC analysis, and GGK-P was 58% (Fig. 4C).
For Fig. 4, A and B, OmpR-P, G129D-P, and P131S-P
were 100%. Binding reactions were prepared, DNase I-treated, and run
on gels as described (22).
 |
RESULTS |
Changes in the Sequence of the Linker Region of ompR Result
in Altered Porin Expression--
Previous results indicate that the
linker is important for interdomain communication in OmpR signaling
(17, 18, 28). To test this hypothesis more directly, we constructed
ompR mutants containing non-native amino acids in place of
the endogenous linker sequence. These sequences replaced amino acids
123-137 of the ompR sequence (QANELPGAPSQEEAV) with one of
the following: QQQQQQQQQQQQQQQ (Q15), QGSTGSSTGSTTGST (GST),
GGGKGGKGGKGGKGG (GGK'), or QKINGELVISLIVES (ELVIS). The resulting
constructs were expressed in the ompF-lacZ fusion strain,
MH513.101, and the ompC-lacZ fusion strain, MH225.101 (27,
29).
We performed liquid -galactosidase assays in media of low and high
osmolarity to determine both the relative expression levels and the
osmoregulatory profiles of the mutants. The results are presented in
Fig. 1. Fig. 1A shows that the
ompF-lacZ fusion strain displays the normal
osmoregulatory profile when OmpR is present, activating expression at
low osmolarity and repressing expression at high osmolarity. Whereas
both Q15 and GST activate expression of ompF, they fail to
repress ompF transcription at high osmolarity. In contrast,
like wild type OmpR, GGK' is capable of both activating expression
of ompF at low osmolarity and repressing its
transcription at high osmolarity. ELVIS does not activate expression of
the ompF-lacZ fusion.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Transcriptional activation by OmpR with
random linker sequences. The effect of ompR
(WT) and the linker mutants ompRQ15
(Q15), ompRGST (GST),
ompRGGK' (GGK'), and ompRELVIS
(ELVIS) on transcriptional activation of
ompF-lacZ (A) and ompC-lacZ
(B) fusions in vivo under conditions of low
(open bars) or high (filled bars) osmolarity.
-Galactosidase assays were performed as described (22). Four
independent assays were performed on each strain; the standard
deviation is indicated by the error bars.
|
|
In Fig. 1B, results obtained in the ompC-lacZ
fusion strain are reported. Wild type OmpR, as well as Q15 and GST,
activates expression of ompC. All three constructs
demonstrate normal osmoregulatory profiles in the expression of this
locus. Neither GGK nor ELVIS is capable of activating transcription
from ompC.
Longer and Shorter Linker Sequences Abrogate ompR
Function--
Because ompRQ15 expressed both
ompF and ompC, it enabled us to examine the
effect of changing the length of the linker sequence without concern
for the specific amino acid residues deleted. We constructed Q15
variants that added or removed amino acids from the linker region of
ompRQ15.
The linker substitutions were examined in liquid -galactosidase
assays. The results are presented in Fig.
2. When Q15 is substituted with a longer
linker region of 20 amino acid residues (Q20), activation of
ompF is greatly diminished, although the construct still
expresses ompF constitutively (Fig. 2A). When OmpR contains a linker of 15 or 13 amino acids, it can activate expression of ompF to normal levels but fails to mediate
repression of this locus at high osmolarity. When the linker region is
shortened to 11 amino acids, some loss of activation is observed, and
this construct still fails to repress ompF. With a linker
length of 10 amino acids, OmpR is barely capable of ompF
transcriptional activation. Further reduction of linker length
completely abolishes transcriptional activation.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Transcriptional activation by OmpR with
various linker lengths. The effect of ompR
(WT) and the linker mutants ompRQ20
(Q20), ompRQ15 (Q15),
ompRQ13 (Q13), ompRQ11
(Q11), ompRQ10 (Q10),
ompRQ9 (Q9), and ompRQ5
(Q5) on transcriptional activation of ompF-lacZ
(A) and ompC-lacZ (B) fusions in
vivo under conditions of low (open bars) and high
(filled bars) osmolarity. -Galactosidase assays were
performed as described (22). At least three independent assays were
performed on each strain; the standard deviation is indicated by the
error bars.
|
|
Interestingly, the results obtained with the ompC-lacZ
fusion clearly show that a decrease in transcriptional activation
occurs with increasing and decreasing linker length (Fig.
2B). Linkers of 20, 13, and 11 residues exhibit normal
patterns of osmoregulated expression of ompC. However,
deviation from the wild type length of 15 decreases the level of
transcription observed. When only 10 residues separate the amino- and
carboxyl-terminal domains of OmpR, no transcription is detected in
logarithmically growing cells. Linkers of even shorter length similarly
have no function. Thus, changing the length of the linker that
separates the two domains of OmpR severely curtails its function
in vivo. This finding has serious implications for function
(signal output) and may limit the validity of comparisons between OmpR
and closely related response regulators. For example, the recently
crystallized OmpR homologue DrrD from Thermotoga maritima
has a linker length of only 5 residues, and the limited interdomain
interface observed may not be relevant to the structure of OmpR
(30-32) (see "Discussion").
Sequence Changes in the Linker Affect OmpR Phosphorylation and
Dephosphorylation by the Kinase EnvZ--
Since two previously
identified point mutants (G129D and P131S) of the OmpR linker region
were OmpF+ OmpC , it was of interest that the
GGK linker substitution also resulted in this phenotype (17, 18). To
characterize the OmpF+ OmpC phenotype
observed in OmpR mutants with a defective linker, we expressed and purified OmpRG129D, OmpRP131S, and
OmpRGGK for in vitro analysis. We hypothesized
that the OmpC phenotype associated with substitutions in
the linker resulted from a defect in interdomain communication, and
thus it was of interest to compare the effects of DNA binding on
phosphorylation and vice versa.
We performed kinase assays to determine whether phosphotransfer from
the EnvZ kinase to the linker mutants was similar to wild type OmpR.
Fig. 3 shows the results of this
experiment. In Fig. 3a, it is apparent that wild type OmpR
is phosphorylated upon incubation with [ -32P]ATP and
EnvZ (lanes 1-3). The phosphorylated EnvZ is turned over as
OmpR is phosphorylated and OmpR-P is dephosphorylated. Upon the
addition of a 2-fold molar excess of the high affinity OmpR binding
site from the ompF promoter (F1), slightly more OmpR-P is
visible (lanes 4-6). In Fig. 3b, P131S is
phosphorylated (lanes 1-3), similar to the wild type OmpR
(Fig. 3a). The addition of F1 DNA in this case only slightly
increases the amount of P131S-P. G129D is also phosphorylated by EnvZ-P
(Fig. 3c, lanes 1-3), and in this case, the
addition of DNA does not affect the phosphoprotein levels (lanes
4-6). GGK is phosphorylated by EnvZ-P (Fig. 3d, lanes 1-3), but the addition of DNA has a remarkable effect
on the level of GGK-P (lanes 4-6), as GGK-P decreases over
time in the phosphorylation reaction when DNA is present. In summary, all three linker mutants are phosphorylated by EnvZ-P, but the effect
of DNA on the GGK linker substitution is dramatic, causing an increase
in turnover of GGK-P (24).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Phosphorylation of linker mutants by EnvZ
115. OmpR (a) and the linker mutants P131S
(b), G129D (c), and GGK (d) were
phosphorylated as described (22). Lanes 1-3 in each panel
show phosphorylation after OmpR has been incubated with
[ -32P]ATP and EnvZ 115 for 1, 2, and 3 h.
Lanes 4-6 show the same reaction performed in the presence
of a 2-fold molar excess of F1 DNA (sequence as shown in Ref.
10).
|
|
In vitro, the EnvZ kinase capable is of phosphorylating both
OmpR and dephosphorylating OmpR-P. When EnvZ is the phosphodonor, the
observed increase in OmpR-P formation upon the addition of DNA is due
to a decrease in the phosphatase activity of EnvZ (14, 24). We can
quantify the effect of DNA on the phosphatase activity of EnvZ, using
an assay that detects the release of Pi (33). Upon incubation
of OmpR, EnvZ, and ATP there is a large increase in
Pi production over time. The average rate of Pi
release in the presence of OmpR is 7.1 nmol/ml/min (Fig.
4A, filled
triangles). The P131S mutant possesses a net ATPase activity
(Pi release) of 6.6 nmol/ml/min, close to the level
observed with wild type OmpR (Fig. 4A, filled
circles). When G129D is incubated with EnvZ and ATP, there is a
low rate of Pi production, 1.0 nmol/ml/min (Fig.
4A, open squares). In the presence of GGK,
Pi production is barely above background (0.3 nmol/ml/min,
Fig. 4A, open diamonds).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
ATPase assay with the linker mutants.
A, closed triangles show the Pi
released after incubation of OmpR with EnvZ and ATP; closed
circles depict the same reaction with P131S; open
squares correspond to G129D; and open diamonds indicate
GGK was used in the reaction. B, the same assay was
performed in the presence a 2-fold molar excess of the C1-C2-C3
oligonucleotide (sequence as shown in Ref. 10). The amount of inorganic
phosphate produced represents the OmpR-stimulated component. At least
three independent experiments were performed over 120 min, and the
values reported represent the averages from all time points taken. The
standard deviation is indicated by the error bars.
|
|
When specific DNA such as the region upstream of the ompC
promoter (C1-C2-C3) is included in the ATPase reaction, the level of
OmpR-stimulated ATPase activity decreases dramatically, falling to 0.3 nmol/ml/min (Fig. 4B, filled triangles). None of
the linker mutants follows this pattern. The ATPase activity in the
presence of P131S does not decrease substantially in the presence of
C1-C2-C3 (4.1 nmol/ml/min, only a 2-fold decrease) (Fig. 4B,
filled circles). The Pi release stimulated by
G129D is also not affected by the presence of DNA, decreasing
~1.5-fold to 0.7 nmol/ml/min (Fig. 4B, open
squares). These differences are small when compared with the
~20-fold reduction in phosphate turnover seen with wild type OmpR
(Compare filled triangles in Fig. 4, A and
B). Both P131S and G129D are known to bind DNA (see below),
and yet DNA binding does not increase the stability of the mutant
phosphoproteins as it does for wild type OmpR-P (Compare
circles or triangles in Fig. 4, A and
B). When specific DNA is included in the GGK reaction, a large increase in Pi production is observed
(Fig. 4B, diamonds). This is the opposite of the
effect of DNA on wild type OmpR. GGK also binds DNA, as shown in the
footprinting assay below. The interaction of GGK with DNA decreases the
stability of GGK-P; this effect is diametrically opposed to that
observed for OmpR (24).
Changes in the Linker Alter DNA Binding at ompC--
We
characterized the DNA binding ability of all three of the linker
mutants using a DNase I footprinting assay. We observed that all three
of the mutants were capable of protecting the ompF promoter
to the same extent as wild type OmpR, as expected by their
OmpF+ phenotypes. Therefore, only the ompC
binding data are shown in Fig. 5.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 5.
DNase I footprinting analysis of OmpR-P,
G129D-P, P131S-P, and GGK-P binding at the ompC
promoter. Previously characterized OmpR binding sites are
indicated to the right of each panel. The scale
on the left of each panel indicates the position of each
band relative to the transcriptional start site of the promoter,
determined by comparison with dideoxy termination sequencing reactions
run previously in parallel with DNase I footprinting experiments.
A, OmpR-P and P131S-P binding to the ompC
promoter. Lane 1 shows the oligonucleotide probe in
the absence of protein and DNase I. Lanes 2 and
10 represent DNase I cleavage in the absence of OmpR.
Lanes 3-8 and 11-16 show the cleavage pattern
obtained when 0.14, 0.29, 0.73, 1.09, 1.6, and 2.1 µM
OmpR-P or P131S-P is included in the reaction. Lane 9 separates the two sections of the panel. B, OmpR-P and
G129D-P bound at ompC. Lanes are the same as
described for panel A. C, OmpR-P and GGK-P
binding to the ompC promoter. Lanes are the same
as described for panel A except lanes 3-8 and
11-16 show the cleavage pattern obtained when 0.4, 0.8, 1.7, 2.5, 3.7, and 5.0 µM GGK-P or OmpR-P is included in
the reaction.
|
|
Fig. 5, A-C, reveals that the three linker mutants have
different DNA binding properties at the ompC promoter
region. Both OmpR-P and P131S-P are capable of protecting the
ompC promoter sequences from 104 to 40 as shown in Fig.
5A. With the G129D point mutant, a different pattern of
protection is observed (Fig. 5B). Whereas OmpR-P
is capable of protecting the entire ompC upstream region
from 104 to 40, G129D-P binds only at the high affinity C1 site,
from 104 to 75. Even at protein concentrations up to 2 µM G129D-P, no binding is evident at the C2 or C3
regions. As observed with the point mutant G129D-P, the substituted
linker mutant GGK-P binds only to the high affinity C1 region (Fig.
5C). It seems likely that the OmpC phenotypes
of two of the linker mutants (G129D and GGK) are due to a DNA binding
defect at the 35 proximal regions of the promoter (sites C2 and C3).
The P131S point mutant may be incapable of interacting productively
with RNA polymerase to initiate transcription because it can bind to
the entire ompC promoter region but does not activate
transcription from this locus. Thus, the underlying defects in G129D
and GGK are distinct from that of P131S, and yet they all give rise to
an OmpF+ OmpC phenotype (see
"Discussion").
 |
DISCUSSION |
Changing the Length of the OmpR Linker Inhibits Transcriptional
Activation--
We chose to use Q15 as a basis for our studies of OmpR
linker length to eliminate concerns that specific amino acid residues were being added or deleted. We discovered that a linker of 13-15 amino acid residues is optimal for OmpR function, with shorter linkers
gradually decreasing the ability of the protein to activate transcription of the porin genes (Fig. 2). This finding has important implications for the likelihood of a similarity in the activation mechanisms of closely related response regulators. One OmpR family member, PhoB, which shares a high degree of sequence homology with
OmpR, has a linker of only 6 amino acid residues (34). Chimeric protein
studies with CheY/PhoB have shown that -helix 5 in the amino
terminus of PhoB inhibits transcriptional activation by the carboxyl
terminus; inhibition is relieved when the amino terminus is
phosphorylated (35). This is unlike the signal propagation mechanism
that controls OmpR signaling. Both the amino and carboxyl termini of
OmpR are necessary for its function, and neither domain is inhibitory
(36). Similarly, although the FixJ family members UhpA and NarL share
high sequence similarity, the carboxyl terminus of NarL is inhibited by
its amino terminus, whereas that of UhpA is not (37, 38). NarL has a
short interdomain linker of 6 amino acid residues, and the
linker of UhpA is 16 residues long (38). Thus, even within the FixJ
family of response regulators to which UhpA and NarL belong, there is a
correlation between linker length and functional differences in the
activation mechanism. In any attempt to predict functional homology
based on sequence analysis, it may be useful to consider the length
of the interdomain linker as well as the respective domain architectures.
An additional point worth noting is that longer linker sequence also
reduced transcriptional activation by OmpR. Thus, a functional OmpR
linker must be 13-15 amino acid residues in length. Because a linker
of 20 amino acid residues should provide a similar increase in local
concentration of the amino and carboxyl termini as a linker of 15 amino
acid residues, it seems likely that the linker of OmpR plays some
active role in directing the appropriate interaction between the two
domains (13, 39, 40). Evidence supporting this view comes from our
studies of limited proteolysis with trypsin, in which we found that
cleavage sites in the linker were sensitive to both phosphorylation and
DNA binding in the amino- and carboxyl-terminal domains, respectively
(13, 41).
Substitutions in the OmpR Linker Reveal New Classes of OmpR
Mutants--
Four different linker sequences were used to examine
whether the sequence of the linker region was important for OmpR
function. Of these, only the ELVIS linker did not activate
transcription (Fig. 1), suggesting that the linker region may require
flexibility and hydrophilicity to allow appropriate interactions
between the amino- and carboxyl-terminal domains of OmpR. In contrast
to the other substitutions, GGK' activates transcription from one locus (ompF+) and not the other
(ompC ). GGK' is also the only construct that
mediates repression of ompF expression at high osmolarity.
The GGK linker is expected to be flexible, which may improve its
ability to activate transcription over that of the ELVIS construct. The
five positively charged residues concentrated in the linker region of
GGK may allow OmpR to more readily adopt a conformation that represses
ompF transcription at high osmolarity than one that allows
expression of ompC (see Fig.
6). Q15 and GST both contain hydrophilic
residues and are predicted to be flexible. Thus, hydrophilicity and
flexibility, as well as the length requirement mentioned above, seem to
be important requirements for OmpR linker function.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Model for the different conformational states
of OmpR. Panel A represents the situation at low
osmolarity, and B at high osmolarity. OmpR is represented as
a two-domain protein, with shaded regions corresponding to
the amino terminus and open regions denoting the DNA-binding
carboxyl terminus. Circles indicate the low osmolarity
conformation that all of the random linker mutants are capable of
assuming, which leads to activation of ompF expression.
Squares represent a conformation accessible to wild type
OmpR and GGK but not to Q15 or GST, which leads to repression loop
formation and repression of ompF transcription.
Triangles show an alternate high osmolarity conformation
that is accessible to wild type OmpR as well as to Q15 and GST (which
GGK cannot adopt) and allows activation of transcription from the
ompC locus. The RNA polymerase complex is included as
a mouse-shaped structure with the -subunit protruding as
a tail-like appendage. A large X indicates that
transcription does not occur under the conditions shown. Panel
C shows which conformations the linker mutants are incapable of
adopting.
|
|
We have shown that OmpR can retain its basic function of
transcriptional activation at the ompF and ompC
promoters when the endogenous amino acid sequence of the linker is
altered (Table I and Fig. 1). However, there are subtleties in porin
gene regulation that are not maintained in the mutants with substituted
linkers, as none of the constructs tested displayed wild type
osmoregulatory profiles (Fig. 1, A and B). With
both OmpRQ15 and OmpRGST, the ability to repress transcription of
ompF at high osmolarity was lost (Fig. 1A). Note
that this does not result from constitutive expression of both porin
genes, as osmoregulation of ompC is normal in these assays
(Fig. 1B).
We present a model in Fig. 6 that incorporates these findings. We
propose that unphosphorylated OmpR does not play a role in the
osmoregulation of porin genes, because it interacts with the promoter
regions with low affinity (10). At low osmolarity, OmpR-P exists
in a conformation that activates expression of ompF but
binds only at the high affinity C1 site and as such fails to activate
transcription from the ompC promoter (Fig. 6A,
circles). At high osmolarity, wild type OmpR-P is
capable of adopting a conformation that represses transcription of
ompF (Fig. 6B, squares) or one that
allows binding at the downstream sites of the ompC promoter
and activation of ompC expression (Fig. 6B,
triangles). The model predicts that two different
conformations of OmpR-P co-exist in the cell at high osmolarity, one of
which represses ompF and another that activates
ompC. The DNA binding sites at the ompF and
ompC promoter regions may induce these alternate conformational changes. We can explain the phenotypes of the linker mutants using this model (Fig. 6C). GGK-P is capable of
activating and repressing ompF but is unable to undergo the
conformational change that would allow binding at the C2 and C3 sites
of the ompC promoter. Q15-P and GST-P are capable of
activating transcription from both ompF and ompC
but cannot access the conformation that would direct repression loop
formation and repress transcription at ompF.
Mutations That Confer an OmpF+ OmpC
Phenotype Do So by Different Mechanisms--
The three linker mutants
described in the present work share an OmpF+
OmpC porin profile but have different molecular defects.
G129D and GGK fail to bind the promoter-proximal C2 and C3 sites of the ompC promoter region, and this explains their failure to
activate transcription from ompC (Fig. 5). However, a
closer examination of mutant phosphorylation properties indicates that
although the mutants have similar DNA binding properties, the G129D and
GGK substitutions have altered the protein in different ways. The G129D
substitution appears to have only quantitatively altered the effect of
DNA on the stability of the phosphoprotein (Figs. 3 and 4). GGK,
however, has a dramatic phenotype (24). The results obtained with GGK
in assays of phosphotransfer and Pi release are
diametrically opposed to those seen with wild type OmpR.
P131S can protect the same sites at ompC to which OmpR
binds, indicating that this residue change most likely interferes with the ability of the P131S protein to contact RNA polymerase, as suggested by previous studies (Figs. 4B and 5) (17).
We have thus examined the molecular phenotypes of three OmpR linker
mutants with the same porin profiles and found that no two behave in
the same way. This result, together with the possibilities for
conformational changes in OmpR-P revealed by the linker substitutions and depicted schematically in Fig. 6, underscores the sophisticated mechanism by which OmpR and EnvZ control the osmoregulation of porin
gene expression.
 |
ACKNOWLEDGEMENTS |
We thank the following for helpful
discussions: Dr. David Farrens, Dr. Scott Landfear, Dr. Richard
Brennan, and Dr. Hans Peter Bächinger, Oregon Health and Science
University; Dr. Edmundo Calva and Mario Flores-Valdez, Universidad
Nacional Autónoma de México, Cuernavaca. Jack Kaplan
(Oregon Health and Science University) provided numerous invaluable
suggestions and advice. Chantal Rison constructed the P131S mutant. We
also thank the members of our laboratory, Don Walthers and Xiuhong
Feng, for helpful discussions.
 |
FOOTNOTES |
*
This work was supported by National Science Foundation Grant
MCB-9904658 and National Institutes of Health Grant GM-58746 (to
L. J. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Predoctoral fellow of the American Heart Association-Northwest Affiliate.
§
Recipient of a Consejo Nacional de Cientificas y Tecnicas
(CONACyT) fellowship from the Mexican government. Current address: Instituto de Biotecnologia, Universidad Nacional Autonoma de Mexico, Ave. Universidad 2001, Cuernavaca, Morelos, 62210 Mexico.
¶
To whom correspondence should be addressed: Dept. of Molecular
Microbiology and Immunology, L-220, Oregon Health and Science University, 3181 S. W. Sam Jackson Park Rd., Portland, OR 97239. Tel.:
503-494-1363; Fax: 503-494-6862; E-mail: KenneyL@ohsu.edu.
Published, JBC Papers in Press, June 20, 2002, DOI 10.1074/jbc.M204122200
 |
ABBREVIATIONS |
The abbreviation used is:
P, phosphorylated
(e.g. OmpR-P).
 |
REFERENCES |
| 1.
|
Hoch, J. A.,
and Silhavy, T. J.
(1995)
Two Component Signal Transduction
, ASM Press, Washington, D. C.
|
| 2.
|
van Alphen, W.,
and Lugtenberg, B.
(1977)
J. Bacteriol.
131,
623-630[Abstract/Free Full Text]
|
| 3.
|
Roberts, D. L.,
Bennett, D. W.,
and Forst, S. A.
(1994)
J. Biol. Chem.
269,
8728-8733[Abstract/Free Full Text]
|
| 4.
|
Delgado, J.,
Forst, S.,
Harlocker, S.,
and Inouye, M.
(1993)
Mol. Microbiol.
10,
1037-1047[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Aiba, H.,
and Mizuno, T.
(1990)
FEBS Lett.
261,
19-22[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Slauch, J. M.,
and Silhavy, T. J.
(1989)
J. Mol. Biol.
210,
281-292[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Kato, M.,
Aiba, H.,
Tate, S.,
Nishimura, Y.,
and Mizuno, T.
(1989)
FEBS Lett.
249,
168-172[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Tate, S.,
Kato, M.,
Nishimura, Y.,
Arata, Y.,
and Mizuno, T.
(1988)
FEBS Lett.
242,
27-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Aiba, H.,
Nakasai, F.,
Mizushima, S.,
and Mizuno, T.
(1989)
J. Biochem. (Tokyo)
106,
5-7[Abstract/Free Full Text]
|
| 10.
|
Head, C. G.,
Tardy, A.,
and Kenney, L. J.
(1998)
J. Mol. Biol.
281,
857-870[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Huang, K. J.,
Lan, C. Y.,
and Igo, M. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2828-2832[Abstract/Free Full Text]
|
| 12.
|
Rampersaud, A.,
Harlocker, S. L.,
and Inouye, M.
(1994)
J. Biol. Chem.
269,
12559-12566[Abstract/Free Full Text]
|
| 13.
|
Ames, S. K.,
Frankema, N.,
and Kenney, L. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11792-11797[Abstract/Free Full Text]
|
| 14.
|
Qin, L.,
Yoshida, T.,
and Inouye, M.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
908-913[Abstract/Free Full Text]
|
| 15.
|
Wootton, J. C.,
and Drummond, M. H.
(1989)
Protein Eng.
2,
535-543[Abstract/Free Full Text]
|
| 16.
|
Argos, P.
(1990)
J. Mol. Biol.
211,
943-958[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Aiba, H.,
Kato, N.,
Tsuzuki, M.,
and Mizuno, T.
(1994)
FEBS Lett.
351,
303-307[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Russo, F. D.,
Slauch, J. M.,
and Silhavy, T. J.
(1993)
J. Mol. Biol.
231,
261-273[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Yamamoto, I.,
Takamatsu, K.,
Ohshima, Y.,
Ujiiye, T.,
and Satoh, T.
(1999)
Biochim. Biophys. Acta
1447,
57-63[Medline]
[Order article via Infotrieve]
|
| 20.
|
Sola, M.,
Gomis-Ruth, F. X.,
Serrano, L.,
Gonzalez, A.,
and Coll, M.
(1999)
J. Mol. Biol.
285,
675-687[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Martinez-Hackert, E.,
and Stock, A. M.
(1997)
Structure
5,
109-124[Medline]
[Order article via Infotrieve]
|
| 22.
|
Mattison, K.,
Oropeza, R.,
Byers, N.,
and Kenney, L. J.
(2002)
J. Mol. Biol.
315,
497-511[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Tran, V. K.,
Oropeza, R.,
and Kenney, L. J.
(2000)
J. Mol. Biol.
299,
1257-1270[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Mattison, K.,
and Kenney, L. J.
(2002)
J. Biol. Chem.
277,
11143-11148[Abstract/Free Full Text]
|
| 25.
|
Russo, F. D.,
and Silhavy, T. J.
(1991)
J. Mol. Biol.
222,
567-580[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Hall, M. N.,
and Silhavy, T. J.
(1979)
J. Bacteriol.
140,
342-350[Abstract/Free Full Text]
|
| 27.
|
Hall, M. N.,
and Silhavy, T. J.
(1981)
J. Mol. Biol.
146,
23-43[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Kanamaru, K.,
and Mizuno, T.
(1992)
J. Biochem. (Tokyo)
111,
425-430[Abstract/Free Full Text]
|
| 29.
|
Hall, M. N.,
and Silhavy, T. J.
(1981)
J. Mol. Biol.
151,
1-15[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bourret, R. B.,
Charon, N. W.,
Stock, A. M.,
and West, A. H.
(2002)
J. Bacteriol.
184,
1-17[Free Full Text]
|
| 31.
|
Buckler, D. R.,
Zhou, Y.,
and Stock, A. M.
(2002)
Structure
10,
153-164[Medline]
[Order article via Infotrieve]
|
| 32.
|
Kenney, L. J.
(2002)
Curr. Opin. Microbiol.
5,
135-141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Kenney, L. J.
(1997)
Arch. Biochem. Biophys.
346,
303-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Blanco, A. G.,
Sola, M.,
Gomis-Ruth, F. X.,
and Coll, M.
(2002)
Structure
10,
701-713[Medline]
[Order article via Infotrieve]
|
| 35.
|
Allen, M. P.,
Zumbrennen, K. B.,
and McCleary, W. R.
(2001)
J. Bacteriol.
183,
2204-2211[Abstract/Free Full Text]
|
| 36.
|
Tsuzuki, M.,
Aiba, H.,
and Mizuno, T.
(1994)
J. Mol. Biol.
242,
607-613[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Baikalov, I.,
Schroder, I.,
Kaczor-Grzeskowiak, M.,
Grzeskowiak, K.,
Gunsalus, R. P.,
and Dickerson, R. E.
(1996)
Biochemistry
35,
11053-11061[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Webber, C. A.,
and Kadner, R. J.
(1997)
Mol. Microbiol.
24,
1039-1048[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Buckler, D. R.,
Anand, G. S.,
and Stock, A. M.
(2000)
Trends Microbiol.
8,
153-156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kenney, L. J.
(2000)
Trends Microbiol.
8,
155-156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Kenney, L. J.,
Bauer, M. D.,
and Silhavy, T. J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8866-8870[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Mellies, F. J. Larabee, M. A. Zarr, K. L. Horback, E. Lorenzen, and D. Mavor
Ler interdomain linker is essential for anti-silencing activity in enteropathogenic Escherichia coli
Microbiology,
December 1, 2008;
154(12):
3624 - 3638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Rhee, W. Sheng, L. K. Morgan, R. Nolet, X. Liao, and L. J. Kenney
Amino Acids Important for DNA Recognition by the Response Regulator OmpR
J. Biol. Chem.,
March 28, 2008;
283(13):
8664 - 8677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Malone, R. Williams, M. Christen, U. Jenal, A. J. Spiers, and P. B. Rainey
The structure-function relationship of WspR, a Pseudomonas fluorescens response regulator with a GGDEF output domain
Microbiology,
April 1, 2007;
153(4):
980 - 994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tapparel, A. Monod, and W. L. Kelley
The DNA-binding domain of the Escherichia coli CpxR two-component response regulator is constitutively active and cannot be fully attenuated by fused adjacent heterologous regulatory domains
Microbiology,
February 1, 2006;
152(2):
431 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Koo, D. Walthers, P. S. Hefty, L. J. Kenney, and R. S. Stephens
ChxR is a transcriptional activator in Chlamydia
PNAS,
January 17, 2006;
103(3):
750 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Depardieu, M. Kolbert, H. Pruul, J. Bell, and P. Courvalin
VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis
Antimicrob. Agents Chemother.,
October 1, 2004;
48(10):
3892 - 3904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Geng, S. Nakano, and M. M. Nakano
Transcriptional Activation by Bacillus subtilis ResD: Tandem Binding to Target Elements and Phosphorylation-Dependent and -Independent Transcriptional Activation
J. Bacteriol.,
April 1, 2004;
186(7):
2028 - 2037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Robinson, T. Wu, and A. M. Stock
Structural Analysis of the Domain Interface in DrrB, a Response Regulator of the OmpR/PhoB Subfamily
J. Bacteriol.,
July 15, 2003;
185(14):
4186 - 4194.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|